Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2011-10-27 Capital/Financing Update
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Trading Halt 3 pages 64.8KB
Capital/Financing Update Classification · 95% confidence The document is a market release dated 28 October 2011 from CBio Limited announcing a trading halt of its securities pending the release of an announcement regarding a material capital raising. The text explicitly states the trading halt is requested pending a capital raising announcement, and there is no financial data or detailed report content included. The document is short (4360 characters) and serves as a notification to the market rather than a financial report or detailed announcement. According to the classification rules, this type of document is best classified as a Capital/Financing Update (CAP) because it relates to a capital raising event and trading halt pending such an announcement.
2011-10-27 English
Lupus Data Published By Oxford Journals 2 pages 35.3KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 28 October 2011 from CBio Limited to the ASX Company Announcements Office. It announces the publication of research data related to their drug XToll in the Oxford Journals publication. The content focuses on the research findings and the strategic importance of this publication for the company. There are no financial statements, no detailed financial performance data, no regulatory certifications, no voting results, no management or board changes, no capital or financing updates, and no earnings or interim reports. The document is a public announcement of a research publication and company strategy validation, not a formal report or regulatory filing. It is relatively short (3497 characters) and serves as a news release to inform investors and the market about the research milestone. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2011-10-27 English
Company Secretary Appointment/Resignation 2 pages 164.7KB
Board/Management Information Classification · 100% confidence The document is a formal announcement dated 28 October 2011 addressed to the ASX Limited Company Announcements Office. It announces the appointment of a new Company Secretary and the resignation of the previous one. The content focuses on management changes and provides background information about the company and its product pipeline. There are no financial statements, earnings data, or detailed financial analysis present. The document length is 3565 characters, which is relatively short and consistent with a management or board change announcement rather than a full report. Therefore, this document fits the category of Board/Management Information (MANG).
2011-10-26 English
Shortfall Allotment 2 pages 175.7KB
Capital/Financing Update Classification · 95% confidence The document is titled 'CAPITAL RAISING UPDATE' and discusses the completion of a placement of shortfall shares under a recent $10.8 million Rights Issue. It provides details on the amount raised, number of shares issued, and the underwriting party. The content focuses on fundraising activities and capital structure changes. The document length is 4021 characters, which is relatively short but contains substantive information about the capital raising event itself, not just an announcement of a report or a brief notice. There is no indication that this is a full financial report, earnings release, or regulatory filing unrelated to capital raising. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2011-10-25 English
Appendix 3B 8 pages 479.7KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number and class of securities, issue price, purpose of the issue, and quotation application to the ASX. It references ASX rules and includes sections on securities ranking, underwriting, and escrow periods. The document is a formal announcement related to the issuance and quotation of additional shares, consistent with regulatory filings for capital raising activities. It does not contain financial statements or management discussion, nor is it a report or presentation. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2011-10-25 English
Section 708A Notice 2 pages 202.8KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001, indicating the issuance of shares without disclosure under Part 6D.2 of the Corporations Act. It provides compliance statements related to the Corporations Act and details about the share issuance on 25 October 2011. The document is short (3908 characters) and serves as a formal announcement of a capital raising event without detailed financial statements or analysis. It is not a full financial report, audit, or management discussion. The content aligns with a Capital/Financing Update, as it informs about new shares issued and compliance with relevant laws. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2011-10-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.